Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06395454

Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU

Procalcitonin as a Sepsis Biomarker in Guiding Antibiotics Treatment Duration in Ventilator Associated Pneumonia in Neuro-ICU: A Randomised Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Universiti Sains Malaysia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Using Procalcitonin Tests to reduce antibiotics duration in Neurosurgical patients with Ventilated Associated Pneumonia

Detailed description

Patients who are more than 18 years old who are admitted to Neurosurgical ICU will be recruited 48hours after ventilation if matches criteria for ventilator associated pneumonia. Patients will be randomised into 2 groups. first group will be procalcitonin guided in addition to conventionally guided sepsis assessment (TWC, CRP, body temperature). second group is only conventionally guided sepsis assessment. in procalcitonin guided group, blood sample will be taken on Day 1 of recruitment and day 5. On day 5 , the procalcitonin level will be compared to recommendations in PRORATA trial. If procalcitonin level is below the level to withhold antibiotics, recommendation will be made to the primary physician to off the antibiotics. Another Procalcitonin level will be repeated on Day 7 to rule out reinfection. This study aims to compare the duration of antibiotics and length of ICU stay among the 2 groups. This study will fill up the gap among the lack of datas in neurosurgical patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTShorten antibiotics duration based on procalcitonin test levelsprocalcitonin test will be taken on day 1 of recruitment as baseline, test done on day 5 will decide whether antibiotics will be withheld, followed by day 7 to determine rate of reinfection.

Timeline

Start date
2024-07-01
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2024-05-02
Last updated
2024-06-03

Source: ClinicalTrials.gov record NCT06395454. Inclusion in this directory is not an endorsement.